| Lactobacillus Acidophilus and Postmenopausal Women (NCT05332626) | Poznan University of Life Sciences | 2022-02-01 |
| A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis (NCT03432533) | Amgen | 2018-02-06 |
| Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in France (NCT02347865) | Amgen | 2015-06-16 |
| Vitamin K as Additive Treatment in Osteoporosis (NCT01232647) | Guy's and St Thomas' NHS Foundation Trust | 2015-04-01 |
| Bone Healing in Healthy and Post-menopausal Osteoporotic Women (NCT01826656) | University College, London | 2014-05-01 |
| Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis (NCT01732770) | Amgen | 2012-11-07 |
| Phase 2 Study of BA058 (Abaloparatide) Transdermal Delivery in Postmenopausal Women With Osteoporosis (NCT01674621) | Radius Health, Inc. | 2012-09-25 |
| A Study of Bonviva/Boniva (Ibandronate) in Biphosphonate-Naïve Women With Post-Menopausal Osteoporosis (NCT01290094) | Hoffmann-La Roche | 2011-04-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of PTH134 in Post-menopausal Women (NCT01224717) | Novartis | 2010-09-01 |
| Intra-venous Zoledronic Acid Once Yearly (NCT00984893) | Novartis Pharmaceuticals | 2008-11-01 |
| 3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 Yrs (NCT00718861) | Novartis Pharmaceuticals | 2008-05-01 |
| A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease. (NCT00503113) | Hoffmann-La Roche | 2007-07-01 |
| Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects (NCT00666627) | Sheffield Teaching Hospitals NHS Foundation Trust | 2007-04-01 |
| BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy. (NCT00545779) | Hoffmann-La Roche | 2006-12-01 |
| ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis. (NCT00545090) | Hoffmann-La Roche | 2006-08-01 |
| SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis. (NCT00545480) | Hoffmann-La Roche | 2006-07-01 |
| A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis. (NCT00377234) | Hoffmann-La Roche | 2006-05-01 |
| A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate) (NCT00303485) | Hoffmann-La Roche | 2006-02-01 |
| A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment (NCT00551174) | Hoffmann-La Roche | 2004-10-01 |
| A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis (NCT02598934) | Hoffmann-La Roche | 2004-08-01 |
| A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva (NCT00081653) | Hoffmann-La Roche | 2004-05-01 |
| DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis (NCT00048074) | Hoffmann-La Roche | 2002-06-01 |
| MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis (NCT00048061) | Hoffmann-La Roche | 2002-04-01 |
| Vitamin K Supplementation in Post-Menopausal Osteopenia (NCT00150969) | University Health Network, Toronto | 2002-01-01 |
| Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005) (NCT00533650) | Merck Sharp & Dohme LLC | 2000-12-01 |